Successful medical therapy for nerve agent intoxication requires early
diagnosis and treatment, Current clinical diagnostic methods do not p
ermit, early or definitive confirmation of intoxication. To improve th
e chances of successful medical therapy against nerve agent intoxicati
on, a sensitive enzyme-based microassay for rapid and accurate quantif
ication of residual soman levels in blood was developed. The new annal
ytical technique is based on the linear correlation between residual e
el acetylcholinesterase activities and the inhibitor concentration. Bl
ood samples were deproteinized with perchloric acid, followed by immed
iate neutralization after deproteinization. The mixtures were centrifu
ged at 3000g and the supernatant was directly assayed for soman, The s
ensitivity of the technique (1.8-1.820 pg/ml blood) is comparable to t
hat attained by GC-FID analysis (250 pg/ml blood). To facilitate routi
ne analysis, the linear range of the assay was optimized to span over
a factor of 100 (0.1-10 nM), with a typical correlation factor of at l
east 0.999 (six standards), The assay accuracy, checked with four diff
erent concentrations of soman, was within +/-10%, The assay capability
in monitoring the pharmacokinetic of soman was validated using both i
n vitro and in vivo rat models. (C) 1998 Academic Press.